life Sciences

Welcome to the 'life Sciences' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'life Sciences'.

Latest blogosphere posts tagged “life Sciences”

• One of world’s most invasive plants provokes native plant to “take itself out”

  
  Thaindian News — Authority: 732
  Washington, December 26 (ANI): In a new research, scientists have found that one of the world’s most invasive plants provokes the native plant to “take itself out”, thus employing a novel means of conquest to establish its supremacy.The research, by an interdisciplinary University of Delaware (UD) team led by ...
  1 day ago

• BSX Pays $22M in DOJ Settlement

  
  Xconomy — Authority: 665
  medical devices , Stents , legal settlements Ryan McBride wrote: Boston Scientific (NYSE: BSX ) said yesterday that it has agreed to pay $22 million in a settlement related to a U.S. Department of Justice investigation of surveys conducted by the Natick, MA-based medical device firm’s subsidiary, ...
  3 days ago

• Novexel Offers Exit to Atlas and Abingworth

  
  Xconomy — Authority: 665
  Antibiotics , VC , deals Ryan McBride wrote: Atlas Venture and Abingworth Management, two venture firms with local offices in Waltham, MA, are in line to exit their investments in French antibiotics developer Novexel, which announced yesterday it would be acquired by London-based drug giant AstraZeneca ...
  3 days ago

• Readers’ Picks: Xconomy San Diego’s Top 5 Stories of 2009

  
  Xconomy — Authority: 665
  deals , Internet , Life Sciences Bruce V. Bigelow wrote: There are many differences between this new world of online media and the old world of ink-on-paper that I used to inhabit. So many, in fact, that sometimes I feel like the earthling in the blockbuster “Avatar” who must take archery lessons and ...
  3 days ago

• MDRNA Grabs $1M Bridge Loan

  
  Xconomy — Authority: 665
  Biotech , deals , RNA Interference Luke Timmerman wrote: MDRNA, the Bothell, WA-based company developing RNA interference technology, said today it has raised $1 million through a debt financing to ensure it has “sufficient resources” to meet its near-term goals of finding a partner or securing more ...
  3 days ago

• Ambit Signs Big Deal With Astellas, Xenomics Alleges Fraud at Sequenom, Arena Seeks FDA Approval for Weight-Loss Drug & More San Diego Life Sciences News

  
  Xconomy — Authority: 665
  Roundup , Life Sciences , deals Bruce V. Bigelow wrote: Despite the fact that there are no snow days in San Diego, we still saw occasional flurries—of life sciences news—in the days before Christmas. Here at Xconomy, we’re wishing everyone happy holidays and an exponential New Year. — Scott ...
  3 days ago

• Readers’ Picks for 2009: Terrafugia’s Maiden Flight, Kindle 2 Taps E Ink, Follica’s War on Baldness, & More

  
  Xconomy — Authority: 665
  IT , Life Sciences , startups Ryan McBride wrote: For the second year straight, our readers have made stories about the biotech startup Follica’s plans to treat baldness, Terrafugia’s street-legal aircraft, and the nonprofit One Laptop Per Child Foundation among Xconomy Boston’s five most popular ...
  3 days ago

• Editor’s Picks: The Best of 2009 From Xconomy Seattle

  
  Xconomy — Authority: 665
  IT , Biotech , cleantech Luke Timmerman wrote: Every day in 2009, I got out of bed and thought about how to create excellent, original stories for Xconomy Seattle. So did my brother-in-arms, editor Greg Huang. We want Xconomy to be a source of original, in-depth, engaging content for you. We are always ...
  3 days ago

• Cell Therapeutics Dangles Exec Bonuses, Oncothyreon’s Turnaround Year, VLST Layoffs, & More Seattle-Area Life Sciences News

  
  Xconomy — Authority: 665
  Roundup , Biotech , deals Luke Timmerman wrote: This was the last week of 2009 that anybody could realistically get deals done, and quite a few did. —Bothell, WA-based OncoGenex Pharmaceuticals (NASDAQ: OGXI ) secured a partnership to develop its experimental prostate cancer treatment with ...
  3 days ago

• See Which Life Sciences Companies Are Getting The $25M State Tax Breaks

  
  Xconomy — Authority: 665
  Biotech , Finances , Politics Luke Timmerman wrote: Quite a few of the companies we cover here at Xconomy received some good fortune this year right before the holidays. These 28 life sciences companies will pocket a total of $25 million in tax incentives, according to a statement from the Massachusetts ...
  3 days ago

• Exponentials R Us: Seven Computer Science Game-Changers from the 2000’s, and Seven More to Come

  
  Xconomy — Authority: 665
  Computers , Internet , wireless Ed Lazowska wrote: Forty years ago, in 1969, Neil Armstrong left footprints on the surface of the moon. It was an extraordinary accomplishment. Also in 1969, with much less fanfare and at much less expense, Len Kleinrock’s programmer Charley Kline sent the first message ...
  3 days ago

• Kala Pharmaceuticals, Stealthy New Company Tied to MIT’s Bob Langer, Gets $2M

  
  Xconomy — Authority: 665
  Biotech , VC , deals Luke Timmerman wrote: MIT’s famously inventive bioengineering professor, Bob Langer , is lending his expertise to yet another fledgling biotech company. Boston-based Kala Pharmaceuticals, which lists Langer on its board of directors, has secured a $2 million equity financing, ...
  3 days ago

• Arena Loses Merck Collaboration After Clogged-Artery Drug Fails Clinical Trial

  
  Xconomy — Authority: 665
  Biotech , deals , Cardiovascular Luke Timmerman wrote: Somebody always delivers some bad news on the slow days before Christmas, and this year, it’s Arena Pharmaceuticals. The San Diego-based biotech company said today that pharma giant Merck has cancelled a research collaboration with Arena after ...
  4 days ago

• HyperMed Files for Chapter 11 Bankruptcy

  
  Xconomy — Authority: 665
  Life Sciences , bankruptcy , medical devices Ryan McBride wrote: Burlington, MA-based medical devices firm HyperMed has filed for Chapter 11 bankruptcy and ceased operations, the Boston Business Journal reports today. The weekly business newspaper, citing bankruptcy filings from Massachusetts District ...
  4 days ago

• pSivida Shares Boom as Eye Drug Passes Pivotal Trial

  
  Xconomy — Authority: 665
  Biotech , diabetes , Eye Disorders Luke Timmerman wrote: Shares of pSivida (NASDAQ: PSDV ) rocketed more than 50 percent this morning on some positive clinical trial news. The Watertown, MA-based company, the developer of a treatment for an eye disorder related to diabetes, said its technology helped ...
  4 days ago

• In Development of Bio-Engineered Skin Tissue, Third Try is Charm for Advanced BioHealing

  
  Xconomy — Authority: 665
  Life Sciences , Biomedical Products , Human Tissue Substitute Bruce V. Bigelow wrote: When it comes to commercializing a bio-engineered human skin substitute that could be used to treat diabetic ulcers and other tissue damage, Kathy McGee has the benefit of a long view. McGee tells me she arrived in ...
  4 days ago

• Joule Biotechnologies Picks Site For Pilot Ethanol Plant in the Desert

  
  Xconomy — Authority: 665
  energy , startups , ethanol Ryan McBride wrote: Joule Biotechnologies has been busy since we last spoke to the company’s leadership around the time it first started talking publicly in July . The Cambridge, MA-based company, which develops fuels and chemicals in a process that mimics photosynthesis, ...
  4 days ago

• Ambit, Buoyed by Astellas Deal, Attempting Rare Switch from Platform to Drug Developer

  
  Xconomy — Authority: 665
  Biotech , people , deals Luke Timmerman wrote: Ambit Biosciences made news last Friday when it pulled in $40 million through a partnership with Japan-based Astellas Pharma. We had the basic gist out fast that morning , but I gathered a lot more detail and insight during a follow-up conversation with ...
  4 days ago

• Biogen Drops Facet Bid, Aveo Reveals IPO Ambitions, Pfizer Partners with Adimab, & More Boston-Area Life Sciences News

  
  Xconomy — Authority: 665
  Roundup , Life Sciences , acquisitions Rebecca Zacks wrote: New England’s drug developers and device makers are squeezing in a few more partnerships, acquisitions, financings, and strategic moves before the year’s end. —Acceleron Pharma, the Cambridge, MA-based biotech that’s building its own ...
  4 days ago

• The Top Five Disruptive Technologies From the Decade of Genomics

  
  Xconomy — Authority: 665
  Biotech , Genomics , Diagnostics Clifford Reid wrote: 1. The Human Genome Project 2. Massively parallel DNA sequencing 3. Personalizing therapeutics via companion diagnostic tests (Herceptin, Gleevec, OncoDX, …) 4. Advanced diagnostics by blood biomarker analysis (e.g. fetal ...
  4 days ago

Comments about life Sciences